摘要
目的：评估比索洛尔对肺源性心脏病（肺心病）心力衰竭的疗效。方法：将肺心病心力衰竭患者40例随机分为两组,常规治疗组18例和比索洛尔组22例。常规治疗组予以抗感染、吸氧、解痉平喘、止咳化痰、纠正水电解质及酸碱平衡等治疗;比索洛尔组在常规治疗的基础上,加比索洛尔1.25~5mg/d,口服2~4周为1疗程,治疗中严密监测各项相关指标。结果：治疗2~4周后,比索洛尔组总有效率为72.27%,常规治疗组为61.11%,两组比较有显著性差异（P〈0.05）。结论：加用比索洛尔治疗肺心病心力衰竭其疗效优于常规治疗组,且未发现明显的副作用。
Objective：Summary purpose evaluation of Bisoprolol on pulmonary heart disease（Cor pulmonale） effects of heart failure.Methods：40 cases of Cor pulmonale heart failure,randomly divided into two groups,General treatment group and 18 cases of Bisoprolol groups 22 cases.Routine treatment group of infection,oxygen,and as antispasmodic and asthma,cough and phlegm,correct solution quality and acid-base balance in the treatment of hydropower;group of Bisoprolol in treatment on the basis of General,and Bisoprolol 1.25~5mg/d,oral 2~4 week for a course,closely monitored in the treatment of the related indicators.Results：In treatment of 2-4 weeks later,Bisoprolol group total effective rate of 88.24%,regular treatment group is 68.75%,more significant differences between the two groups（P0.05）.Conclusion：Curative effect of Bisoprolol in treatment of Cor pulmonale heart failure it is superior to conventional treatment,and found no obvious side effects.
出处
《亚太传统医药》
2011年第9期81-82,共2页
Asia-Pacific Traditional Medicine
关键词
肺源性心脏病
比索洛尔
心力衰竭
Pulmonary Heart Disease
Bisoprolol
Congestive Heart Failure
